OPPORTUNITIES abound beyond Singapore's shores, and specialist healthcare provider Singapore Medical Group (SMG) is raring to go.

THE following companies saw new developments that may affect trading of their securities on Friday:

SINGAPORE Medical Group (SMG) has proposed to acquire the 50 per cent stake it does not own in its joint-venture company, SMG International Vietnam (SMG IV), for S$3.04 million as part of plans to expand in Vietnam amid rising private healthcare demand.

UOB Kay Hian (UOBKH) is maintaining its “buy” call and target price of 48 cents on Singapore Medical Group (SMG). This is pegged to its peers’ average price-to-earnings (PE) of 17x 2021 PE and is believed to give the counter a 45.5% upside from its 33 cent price, analyst Lucas Teng writes in a...

THE H1 net profit of Singapore Medical Group (SMG) more than doubled to S$7.2 million for the half-year period ended June 30, up from S$3.5 million a year ago due to rising demand for the group's aesthetics, Lasik and diagnostic imaging-related services.

SINGAPORE Medical Group's (SMG) H1 net profit more than doubled to S$7.2 million for the half-year period ended June 30, 2021, up from S$3.5 million a year ago due to rising demand in the group's aesthetics, Lasik and diagnostic imaging-related services.

THE following companies saw new developments that may affect trading of their securities on Tuesday:

Catalist-listed Singapore Medical Group (SMG) has reported earnings of $7.2 million for the 1HFY2021 ended June, an increase of 108.2% y-o-y. This translates to earnings per share (EPS) of 1.49 cents for the 1HFY2021, compared to 0.79 cents the year before. Total revenue for the period came in at $4...

Singapore Medical Group has announced revenue of $24.8 million for the 1QFY2021, making this the group’s all-time quarterly high. The quarter’s revenue represents a 7.6% y-o-y growth from the corresponding period the year before. The higher topline was mainly attributed to an increase in the gro...

CATALIST-listed Singapore Medical Group (SMG) announced on Monday a 22.2 per cent increase in first-quarter net profit to S$3.8 million from S$3.1 million in the previous year, due to a surge in demand for the group's aesthetics, Lasik and diagnostic imaging-related services.